Vitamin D deficiency and kidney hyperfiltration: a mechanism of kidney injury?
暂无分享,去创建一个
[1] N. Potischman,et al. Vitamin D status in the United States, 2011-2014. , 2019, The American journal of clinical nutrition.
[2] R. Feinn,et al. Role of Vitamin D and Its Analogues in Diabetic Nephropathy: A Meta‐analysis , 2019, The American journal of the medical sciences.
[3] A. Köttgen,et al. Negative effect of vitamin D on kidney function: a Mendelian randomization study , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] J. Manson,et al. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics. , 2018, Contemporary clinical trials.
[5] T. Yoo,et al. Severe vitamin D deficiency is a risk factor for renal hyperfiltration. , 2018, The American journal of clinical nutrition.
[6] L. Kingsley,et al. Vitamin D Status and Kidney Function Decline in HIV-Infected Men: A Longitudinal Study in the Multicenter AIDS Cohort Study. , 2017, AIDS research and human retroviruses.
[7] Mary B Leonard,et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. , 2017, Kidney international.
[8] Jin Deng,et al. Calcitriol in the treatment of IgA nephropathy with non-nephrotic range proteinuria: a meta-analysis of randomized controlled trials . , 2017, Clinical nephrology.
[9] B. Kestenbaum,et al. Serum 25-Hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-Based Population of Older Adults , 2012, Annals of Internal Medicine.
[10] D. Gardner,et al. Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats. , 2012, American journal of physiology. Renal physiology.
[11] R. Light,et al. Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate. , 2011, Kidney international.
[12] C. Gordon,et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[13] JoAnn E. Manson,et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.
[14] H. Parving,et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial , 2010, The Lancet.
[15] N. Powe,et al. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.
[16] R. Bilous,et al. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis , 2009, Diabetologia.
[17] C. Zoccali,et al. Vitamin D levels and patient outcome in chronic kidney disease. , 2009, Kidney international.
[18] B. Astor,et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.
[19] Keith C. Norris,et al. Hypovitaminosis D in chronic kidney disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[20] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[21] B. Kestenbaum,et al. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] A. Levin,et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. , 2007, Kidney international.
[23] J. Chandler,et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation , 2006, Journal of internal medicine.
[24] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[25] Shu Q. Liu,et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .
[26] Shu Q. Liu,et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.
[27] Teven,et al. EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .
[28] B. Brenner,et al. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. , 1982, The American journal of medicine.